Compile Data Set for Download or QSAR

Found 34 hits Enz. Inhib. hit(s) with all data for entry = 50010936   

Target/Host (Institution)	Ligand	Target/Host Links	Ligand Links	Trg + Lig Links	Ki nM	ΔG° kJ/mole	IC50 nM	Kd nM	EC50/IC50 nM	koff s-1	kon M-1s-1	pH	Temp °C
Integrin alpha-IIb/beta-3 (Homo sapiens (Human))	BDBM50100346 ((S)-2-(3,5-Dimethyl-isoxazole-4-sulfonylamino)-3-[...) Show SMILES Cc1noc(C)c1S(=O)(=O)N[C@@H](CNC(=O)N1CCC2(CC1)CCN(CC2)c1ccncc1)C(O)=O Show InChI InChI=1S/C23H32N6O6S/c1-16-20(17(2)35-26-16)36(33,34)27-19(21(30)31)15-25-22(32)29-13-7-23(8-14-29)5-11-28(12-6-23)18-3-9-24-10-4-18/h3-4,9-10,19,27H,5-8,11-15H2,1-2H3,(H,25,32)(H,30,31)/t19-/m0/s1	PDB KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Patents Similars	PubMed	n/a	n/a	1	n/a	n/a	n/a	n/a	n/a	n/a
COR Therapeutics, Inc Curated by ChEMBL					Assay Description Inhibitory concentration of the compound against alphaV-beta3 integrin				Bioorg Med Chem Lett 11: 1289-92 (2001) BindingDB Entry DOI: 10.7270/Q22N51KQ
					More data for this Ligand-Target Pair
Integrin alpha-IIb/beta-3 (Homo sapiens (Human))	BDBM50100350 ((S)-5-Oxo-5-(9-pyridin-4-yl-3,9-diaza-spiro[5.5]un...) Show SMILES Cc1ccc(cc1)S(=O)(=O)N[C@@H](CCC(=O)N1CCC2(CC1)CCN(CC2)c1ccncc1)C(O)=O Show InChI InChI=1S/C26H34N4O5S/c1-20-2-4-22(5-3-20)36(34,35)28-23(25(32)33)6-7-24(31)30-18-12-26(13-19-30)10-16-29(17-11-26)21-8-14-27-15-9-21/h2-5,8-9,14-15,23,28H,6-7,10-13,16-19H2,1H3,(H,32,33)/t23-/m0/s1	PDB KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Patents	PubMed	n/a	n/a	2	n/a	n/a	n/a	n/a	n/a	n/a
COR Therapeutics, Inc Curated by ChEMBL					Assay Description Inhibitory concentration of the compound against alphaV-beta3 integrin				Bioorg Med Chem Lett 11: 1289-92 (2001) BindingDB Entry DOI: 10.7270/Q22N51KQ
					More data for this Ligand-Target Pair
Integrin alpha-IIb/beta-3 (Homo sapiens (Human))	BDBM50092105 ((S)-2-(3,5-Dimethyl-isoxazole-4-sulfonylamino)-5-o...) Show SMILES Cc1noc(C)c1S(=O)(=O)N[C@@H](CCC(=O)N1CCC2(CC1)CCN(CC2)c1ccncc1)C(O)=O Show InChI InChI=1S/C24H33N5O6S/c1-17-22(18(2)35-26-17)36(33,34)27-20(23(31)32)3-4-21(30)29-15-9-24(10-16-29)7-13-28(14-8-24)19-5-11-25-12-6-19/h5-6,11-12,20,27H,3-4,7-10,13-16H2,1-2H3,(H,31,32)/t20-/m0/s1	PDB KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Patents Similars	PubMed	n/a	n/a	2	n/a	n/a	n/a	n/a	n/a	n/a
COR Therapeutics, Inc Curated by ChEMBL					Assay Description Inhibition of binding of fibrinogen to purified human GPIIb-IIIa in ELISA				Bioorg Med Chem Lett 11: 1289-92 (2001) BindingDB Entry DOI: 10.7270/Q22N51KQ
					More data for this Ligand-Target Pair
Integrin alpha-IIb/beta-3 (Homo sapiens (Human))	BDBM50100344 ((S)-2-Butoxycarbonylamino-5-oxo-5-(9-pyridin-4-yl-...) Show SMILES CCCCOC(=O)N[C@@H](CCC(=O)N1CCC2(CC1)CCN(CC2)c1ccncc1)C(O)=O Show InChI InChI=1S/C24H36N4O5/c1-2-3-18-33-23(32)26-20(22(30)31)4-5-21(29)28-16-10-24(11-17-28)8-14-27(15-9-24)19-6-12-25-13-7-19/h6-7,12-13,20H,2-5,8-11,14-18H2,1H3,(H,26,32)(H,30,31)/t20-/m0/s1	PDB KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Patents Similars	PubMed	n/a	n/a	4	n/a	n/a	n/a	n/a	n/a	n/a
COR Therapeutics, Inc Curated by ChEMBL					Assay Description Inhibition of binding of fibrinogen to purified human GPIIb-IIIa in ELISA				Bioorg Med Chem Lett 11: 1289-92 (2001) BindingDB Entry DOI: 10.7270/Q22N51KQ
					More data for this Ligand-Target Pair
Integrin alpha-IIb/beta-3 (Homo sapiens (Human))	BDBM50100351 ((S)-2-Benzyloxycarbonylamino-5-oxo-5-(9-pyridin-4-...) Show SMILES OC(=O)[C@H](CCC(=O)N1CCC2(CC1)CCN(CC2)c1ccncc1)NC(=O)OCc1ccccc1 Show InChI InChI=1S/C27H34N4O5/c32-24(7-6-23(25(33)34)29-26(35)36-20-21-4-2-1-3-5-21)31-18-12-27(13-19-31)10-16-30(17-11-27)22-8-14-28-15-9-22/h1-5,8-9,14-15,23H,6-7,10-13,16-20H2,(H,29,35)(H,33,34)/t23-/m0/s1	PDB KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Patents Similars	PubMed	n/a	n/a	7	n/a	n/a	n/a	n/a	n/a	n/a
COR Therapeutics, Inc Curated by ChEMBL					Assay Description Inhibition of binding of fibrinogen to purified human GPIIb-IIIa in ELISA				Bioorg Med Chem Lett 11: 1289-92 (2001) BindingDB Entry DOI: 10.7270/Q22N51KQ
					More data for this Ligand-Target Pair
Integrin alpha-IIb/beta-3 (Homo sapiens (Human))	BDBM50100347 ((S)-2-(Butane-1-sulfonylamino)-5-oxo-5-(9-pyridin-...) Show SMILES CCCCS(=O)(=O)N[C@@H](CCC(=O)N1CCC2(CC1)CCN(CC2)c1ccncc1)C(O)=O Show InChI InChI=1S/C23H36N4O5S/c1-2-3-18-33(31,32)25-20(22(29)30)4-5-21(28)27-16-10-23(11-17-27)8-14-26(15-9-23)19-6-12-24-13-7-19/h6-7,12-13,20,25H,2-5,8-11,14-18H2,1H3,(H,29,30)/t20-/m0/s1	PDB KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem	PubMed	n/a	n/a	23	n/a	n/a	n/a	n/a	n/a	n/a
COR Therapeutics, Inc Curated by ChEMBL					Assay Description Inhibition of binding of fibrinogen to purified human GPIIb-IIIa in ELISA				Bioorg Med Chem Lett 11: 1289-92 (2001) BindingDB Entry DOI: 10.7270/Q22N51KQ
					More data for this Ligand-Target Pair
Integrin alpha-IIb/beta-3 (Homo sapiens (Human))	BDBM50100352 (3-Oxo-3-[4-(9-pyridin-4-yl-3,9-diaza-spiro[5.5]und...) Show SMILES OC(=O)CC(=O)N1CCC(CC1)C(=O)N1CCC2(CC1)CCN(CC2)c1ccncc1 Show InChI InChI=1S/C23H32N4O4/c28-20(17-21(29)30)26-11-3-18(4-12-26)22(31)27-15-7-23(8-16-27)5-13-25(14-6-23)19-1-9-24-10-2-19/h1-2,9-10,18H,3-8,11-17H2,(H,29,30)	PDB KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia antibodypedia GoogleScholar AffyNet	CHEMBL KEGG PC cid PC sid UniChem Patents Similars	PubMed	n/a	n/a	43	n/a	n/a	n/a	n/a	n/a	n/a
COR Therapeutics, Inc Curated by ChEMBL					Assay Description Inhibitory concentration of the compound against alphaV-beta3 integrin				Bioorg Med Chem Lett 11: 1289-92 (2001) BindingDB Entry DOI: 10.7270/Q22N51KQ
					More data for this Ligand-Target Pair
Integrin alpha-IIb/beta-3 (Homo sapiens (Human))	BDBM50100356 (3-[9-(4-Carbamimidoyl-phenyl)-3,9-diaza-spiro[5.5]...) Show SMILES NC(=N)c1ccc(cc1)N1CCC2(CCN(CCC(O)=O)CC2)CC1 Show InChI InChI=1S/C19H28N4O2/c20-18(21)15-1-3-16(4-2-15)23-13-8-19(9-14-23)6-11-22(12-7-19)10-5-17(24)25/h1-4H,5-14H2,(H3,20,21)(H,24,25)	PDB KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem	PubMed	n/a	n/a	160	n/a	n/a	n/a	n/a	n/a	n/a
COR Therapeutics, Inc Curated by ChEMBL					Assay Description Inhibitory concentration of the compound against alphaV-beta3 integrin				Bioorg Med Chem Lett 11: 1289-92 (2001) BindingDB Entry DOI: 10.7270/Q22N51KQ
					More data for this Ligand-Target Pair
Integrin alpha-IIb/beta-3 (Homo sapiens (Human))	BDBM50100343 (2-{1-[9-(4-pyridyl)-3,9-diazaspiro[5.5]undec-3-ylc...) Show SMILES OC(=O)COC1CCN(CC1)C(=O)N1CCC2(CC1)CCN(CC2)c1ccncc1 Show InChI InChI=1S/C22H32N4O4/c27-20(28)17-30-19-3-11-25(12-4-19)21(29)26-15-7-22(8-16-26)5-13-24(14-6-22)18-1-9-23-10-2-18/h1-2,9-10,19H,3-8,11-17H2,(H,27,28)	PDB KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Patents Similars	PubMed	n/a	n/a	210	n/a	n/a	n/a	n/a	n/a	n/a
COR Therapeutics, Inc Curated by ChEMBL					Assay Description Inhibition of binding of fibrinogen to purified human GPIIb-IIIa in ELISA				Bioorg Med Chem Lett 11: 1289-92 (2001) BindingDB Entry DOI: 10.7270/Q22N51KQ
					More data for this Ligand-Target Pair
Integrin alpha-IIb/beta-3 (Homo sapiens (Human))	BDBM50100353 (5-Oxo-5-(9-pyridin-4-yl-3,9-diaza-spiro[5.5]undec-...) Show SMILES OC(=O)CCCC(=O)N1CCC2(CC1)CCN(CC2)c1ccncc1 Show InChI InChI=1S/C19H27N3O3/c23-17(2-1-3-18(24)25)22-14-8-19(9-15-22)6-12-21(13-7-19)16-4-10-20-11-5-16/h4-5,10-11H,1-3,6-9,12-15H2,(H,24,25)	PDB KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Patents Similars	PubMed	n/a	n/a	240	n/a	n/a	n/a	n/a	n/a	n/a
COR Therapeutics, Inc Curated by ChEMBL					Assay Description Inhibitory concentration of the compound against alphaV-beta3 integrin				Bioorg Med Chem Lett 11: 1289-92 (2001) BindingDB Entry DOI: 10.7270/Q22N51KQ
					More data for this Ligand-Target Pair
Integrin alpha-IIb/beta-3 (Homo sapiens (Human))	BDBM50100355 (6-Oxo-6-(9-pyridin-4-yl-3,9-diaza-spiro[5.5]undec-...) Show SMILES OC(=O)CCCCC(=O)N1CCC2(CC1)CCN(CC2)c1ccncc1 Show InChI InChI=1S/C20H29N3O3/c24-18(3-1-2-4-19(25)26)23-15-9-20(10-16-23)7-13-22(14-8-20)17-5-11-21-12-6-17/h5-6,11-12H,1-4,7-10,13-16H2,(H,25,26)	PDB KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Patents Similars	PubMed	n/a	n/a	260	n/a	n/a	n/a	n/a	n/a	n/a
COR Therapeutics, Inc Curated by ChEMBL					Assay Description Inhibitory concentration of the compound against alphaV-beta3 integrin				Bioorg Med Chem Lett 11: 1289-92 (2001) BindingDB Entry DOI: 10.7270/Q22N51KQ
					More data for this Ligand-Target Pair
Integrin alpha-IIb/beta-3 (Homo sapiens (Human))	BDBM50100342 (7-Oxo-7-(9-pyridin-4-yl-3,9-diaza-spiro[5.5]undec-...) Show SMILES OC(=O)CCCCCC(=O)N1CCC2(CC1)CCN(CC2)c1ccncc1 Show InChI InChI=1S/C21H31N3O3/c25-19(4-2-1-3-5-20(26)27)24-16-10-21(11-17-24)8-14-23(15-9-21)18-6-12-22-13-7-18/h6-7,12-13H,1-5,8-11,14-17H2,(H,26,27)	PDB KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Patents Similars	PubMed	n/a	n/a	270	n/a	n/a	n/a	n/a	n/a	n/a
COR Therapeutics, Inc Curated by ChEMBL					Assay Description Inhibition of binding of fibrinogen to purified human GPIIb-IIIa in ELISA				Bioorg Med Chem Lett 11: 1289-92 (2001) BindingDB Entry DOI: 10.7270/Q22N51KQ
					More data for this Ligand-Target Pair
Integrin alpha-IIb/beta-3 (Homo sapiens (Human))	BDBM50100357 (8-Oxo-8-(9-pyridin-4-yl-3,9-diaza-spiro[5.5]undec-...) Show SMILES OC(=O)CCCCCCC(=O)N1CCC2(CC1)CCN(CC2)c1ccncc1 Show InChI InChI=1S/C22H33N3O3/c26-20(5-3-1-2-4-6-21(27)28)25-17-11-22(12-18-25)9-15-24(16-10-22)19-7-13-23-14-8-19/h7-8,13-14H,1-6,9-12,15-18H2,(H,27,28)	PDB KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Patents Similars	PubMed	n/a	n/a	1.16E+3	n/a	n/a	n/a	n/a	n/a	n/a
COR Therapeutics, Inc Curated by ChEMBL					Assay Description Inhibitory concentration of the compound against alphaV-beta3 integrin				Bioorg Med Chem Lett 11: 1289-92 (2001) BindingDB Entry DOI: 10.7270/Q22N51KQ
					More data for this Ligand-Target Pair
Integrin alpha-IIb/beta-3 (Homo sapiens (Human))	BDBM50100345 (5-[9-(4-Carbamimidoyl-benzoyl)-3,9-diaza-spiro[5.5...) Show SMILES NC(=N)c1ccc(cc1)C(=O)N1CCC2(CCN(CC2)C(=O)CCCC(O)=O)CC1 Show InChI InChI=1S/C22H30N4O4/c23-20(24)16-4-6-17(7-5-16)21(30)26-14-10-22(11-15-26)8-12-25(13-9-22)18(27)2-1-3-19(28)29/h4-7H,1-3,8-15H2,(H3,23,24)(H,28,29)	PDB KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Patents Similars	PubMed	n/a	n/a	3.50E+3	n/a	n/a	n/a	n/a	n/a	n/a
COR Therapeutics, Inc Curated by ChEMBL					Assay Description Inhibitory concentration of the compound against alphaV-beta3 integrin				Bioorg Med Chem Lett 11: 1289-92 (2001) BindingDB Entry DOI: 10.7270/Q22N51KQ
					More data for this Ligand-Target Pair
Integrin alpha-IIb/beta-3 (Homo sapiens (Human))	BDBM50100349 (3-[9-(4-Carbamimidoyl-benzoyl)-3,9-diaza-spiro[5.5...) Show SMILES NC(=N)c1ccc(cc1)C(=O)N1CCC2(CCN(CC2)C(=O)CC(O)=O)CC1 Show InChI InChI=1S/C20H26N4O4/c21-18(22)14-1-3-15(4-2-14)19(28)24-11-7-20(8-12-24)5-9-23(10-6-20)16(25)13-17(26)27/h1-4H,5-13H2,(H3,21,22)(H,26,27)	PDB KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia antibodypedia GoogleScholar AffyNet	CHEMBL KEGG PC cid PC sid UniChem	PubMed	n/a	n/a	9.70E+3	n/a	n/a	n/a	n/a	n/a	n/a
COR Therapeutics, Inc Curated by ChEMBL					Assay Description Inhibitory concentration of the compound against alphaV-beta3 integrin				Bioorg Med Chem Lett 11: 1289-92 (2001) BindingDB Entry DOI: 10.7270/Q22N51KQ
					More data for this Ligand-Target Pair
Integrin alpha-IIb/beta-3 (Homo sapiens (Human))	BDBM50100348 (4-[9-(4-Carbamimidoyl-benzoyl)-3,9-diaza-spiro[5.5...) Show SMILES NC(=N)c1ccc(cc1)C(=O)N1CCC2(CCN(CC2)C(=O)CCC(O)=O)CC1 Show InChI InChI=1S/C21H28N4O4/c22-19(23)15-1-3-16(4-2-15)20(29)25-13-9-21(10-14-25)7-11-24(12-8-21)17(26)5-6-18(27)28/h1-4H,5-14H2,(H3,22,23)(H,27,28)	PDB KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Patents Similars	PubMed	n/a	n/a	1.50E+4	n/a	n/a	n/a	n/a	n/a	n/a
COR Therapeutics, Inc Curated by ChEMBL					Assay Description Inhibition of binding of fibrinogen to purified human GPIIb-IIIa in ELISA				Bioorg Med Chem Lett 11: 1289-92 (2001) BindingDB Entry DOI: 10.7270/Q22N51KQ
					More data for this Ligand-Target Pair
Integrin alpha-V/beta-3 (Homo sapiens (Human))	BDBM50100348 (4-[9-(4-Carbamimidoyl-benzoyl)-3,9-diaza-spiro[5.5...) Show SMILES NC(=N)c1ccc(cc1)C(=O)N1CCC2(CCN(CC2)C(=O)CCC(O)=O)CC1 Show InChI InChI=1S/C21H28N4O4/c22-19(23)15-1-3-16(4-2-15)20(29)25-13-9-21(10-14-25)7-11-24(12-8-21)17(26)5-6-18(27)28/h1-4H,5-14H2,(H3,22,23)(H,27,28)	PDB UniProtKB/SwissProt antibodypedia antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Patents Similars	PubMed	n/a	n/a	>1.00E+5	n/a	n/a	n/a	n/a	n/a	n/a
COR Therapeutics, Inc Curated by ChEMBL					Assay Description Inhibitory concentration of the compound against alphaV-beta3 integrin				Bioorg Med Chem Lett 11: 1289-92 (2001) BindingDB Entry DOI: 10.7270/Q22N51KQ
					More data for this Ligand-Target Pair
Integrin alpha-V/beta-3 (Homo sapiens (Human))	BDBM50100349 (3-[9-(4-Carbamimidoyl-benzoyl)-3,9-diaza-spiro[5.5...) Show SMILES NC(=N)c1ccc(cc1)C(=O)N1CCC2(CCN(CC2)C(=O)CC(O)=O)CC1 Show InChI InChI=1S/C20H26N4O4/c21-18(22)14-1-3-15(4-2-14)19(28)24-11-7-20(8-12-24)5-9-23(10-6-20)16(25)13-17(26)27/h1-4H,5-13H2,(H3,21,22)(H,26,27)	PDB UniProtKB/SwissProt antibodypedia antibodypedia GoogleScholar AffyNet	CHEMBL KEGG PC cid PC sid UniChem	PubMed	n/a	n/a	>1.00E+5	n/a	n/a	n/a	n/a	n/a	n/a
COR Therapeutics, Inc Curated by ChEMBL					Assay Description Inhibition of binding of fibrinogen to purified human GPIIb-IIIa in ELISA				Bioorg Med Chem Lett 11: 1289-92 (2001) BindingDB Entry DOI: 10.7270/Q22N51KQ
					More data for this Ligand-Target Pair
Integrin alpha-V/beta-3 (Homo sapiens (Human))	BDBM50100355 (6-Oxo-6-(9-pyridin-4-yl-3,9-diaza-spiro[5.5]undec-...) Show SMILES OC(=O)CCCCC(=O)N1CCC2(CC1)CCN(CC2)c1ccncc1 Show InChI InChI=1S/C20H29N3O3/c24-18(3-1-2-4-19(25)26)23-15-9-20(10-16-23)7-13-22(14-8-20)17-5-11-21-12-6-17/h5-6,11-12H,1-4,7-10,13-16H2,(H,25,26)	PDB UniProtKB/SwissProt antibodypedia antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Patents Similars	PubMed	n/a	n/a	>1.00E+5	n/a	n/a	n/a	n/a	n/a	n/a
COR Therapeutics, Inc Curated by ChEMBL					Assay Description Inhibition of binding of fibrinogen to purified human GPIIb-IIIa in ELISA				Bioorg Med Chem Lett 11: 1289-92 (2001) BindingDB Entry DOI: 10.7270/Q22N51KQ
					More data for this Ligand-Target Pair
Integrin alpha-V/beta-3 (Homo sapiens (Human))	BDBM50100356 (3-[9-(4-Carbamimidoyl-phenyl)-3,9-diaza-spiro[5.5]...) Show SMILES NC(=N)c1ccc(cc1)N1CCC2(CCN(CCC(O)=O)CC2)CC1 Show InChI InChI=1S/C19H28N4O2/c20-18(21)15-1-3-16(4-2-15)23-13-8-19(9-14-23)6-11-22(12-7-19)10-5-17(24)25/h1-4H,5-14H2,(H3,20,21)(H,24,25)	PDB UniProtKB/SwissProt antibodypedia antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem	PubMed	n/a	n/a	>1.00E+5	n/a	n/a	n/a	n/a	n/a	n/a
COR Therapeutics, Inc Curated by ChEMBL					Assay Description Inhibitory concentration of the compound against alphaV-beta3 integrin				Bioorg Med Chem Lett 11: 1289-92 (2001) BindingDB Entry DOI: 10.7270/Q22N51KQ
					More data for this Ligand-Target Pair
Integrin alpha-V/beta-3 (Homo sapiens (Human))	BDBM50100350 ((S)-5-Oxo-5-(9-pyridin-4-yl-3,9-diaza-spiro[5.5]un...) Show SMILES Cc1ccc(cc1)S(=O)(=O)N[C@@H](CCC(=O)N1CCC2(CC1)CCN(CC2)c1ccncc1)C(O)=O Show InChI InChI=1S/C26H34N4O5S/c1-20-2-4-22(5-3-20)36(34,35)28-23(25(32)33)6-7-24(31)30-18-12-26(13-19-30)10-16-29(17-11-26)21-8-14-27-15-9-21/h2-5,8-9,14-15,23,28H,6-7,10-13,16-19H2,1H3,(H,32,33)/t23-/m0/s1	PDB UniProtKB/SwissProt antibodypedia antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Patents	PubMed	n/a	n/a	>1.00E+5	n/a	n/a	n/a	n/a	n/a	n/a
COR Therapeutics, Inc Curated by ChEMBL					Assay Description Inhibition of binding of fibrinogen to purified human GPIIb-IIIa in ELISA				Bioorg Med Chem Lett 11: 1289-92 (2001) BindingDB Entry DOI: 10.7270/Q22N51KQ
					More data for this Ligand-Target Pair
Integrin alpha-V/beta-3 (Homo sapiens (Human))	BDBM50100354 (6-[9-(4-Carbamimidoyl-benzoyl)-3,9-diaza-spiro[5.5...) Show SMILES NC(=N)c1ccc(cc1)C(=O)N1CCC2(CCN(CC2)C(=O)CCCCC(O)=O)CC1 Show InChI InChI=1S/C23H32N4O4/c24-21(25)17-5-7-18(8-6-17)22(31)27-15-11-23(12-16-27)9-13-26(14-10-23)19(28)3-1-2-4-20(29)30/h5-8H,1-4,9-16H2,(H3,24,25)(H,29,30)	PDB UniProtKB/SwissProt antibodypedia antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	PubMed	n/a	n/a	>1.00E+5	n/a	n/a	n/a	n/a	n/a	n/a
COR Therapeutics, Inc Curated by ChEMBL					Assay Description Inhibition of binding of fibrinogen to purified human GPIIb-IIIa in ELISA				Bioorg Med Chem Lett 11: 1289-92 (2001) BindingDB Entry DOI: 10.7270/Q22N51KQ
					More data for this Ligand-Target Pair
Integrin alpha-V/beta-3 (Homo sapiens (Human))	BDBM50100347 ((S)-2-(Butane-1-sulfonylamino)-5-oxo-5-(9-pyridin-...) Show SMILES CCCCS(=O)(=O)N[C@@H](CCC(=O)N1CCC2(CC1)CCN(CC2)c1ccncc1)C(O)=O Show InChI InChI=1S/C23H36N4O5S/c1-2-3-18-33(31,32)25-20(22(29)30)4-5-21(28)27-16-10-23(11-17-27)8-14-26(15-9-23)19-6-12-24-13-7-19/h6-7,12-13,20,25H,2-5,8-11,14-18H2,1H3,(H,29,30)/t20-/m0/s1	PDB UniProtKB/SwissProt antibodypedia antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem	PubMed	n/a	n/a	>1.00E+5	n/a	n/a	n/a	n/a	n/a	n/a
COR Therapeutics, Inc Curated by ChEMBL					Assay Description Inhibitory concentration of the compound against alphaV-beta3 integrin				Bioorg Med Chem Lett 11: 1289-92 (2001) BindingDB Entry DOI: 10.7270/Q22N51KQ
					More data for this Ligand-Target Pair
Integrin alpha-V/beta-3 (Homo sapiens (Human))	BDBM50100351 ((S)-2-Benzyloxycarbonylamino-5-oxo-5-(9-pyridin-4-...) Show SMILES OC(=O)[C@H](CCC(=O)N1CCC2(CC1)CCN(CC2)c1ccncc1)NC(=O)OCc1ccccc1 Show InChI InChI=1S/C27H34N4O5/c32-24(7-6-23(25(33)34)29-26(35)36-20-21-4-2-1-3-5-21)31-18-12-27(13-19-31)10-16-30(17-11-27)22-8-14-28-15-9-22/h1-5,8-9,14-15,23H,6-7,10-13,16-20H2,(H,29,35)(H,33,34)/t23-/m0/s1	PDB UniProtKB/SwissProt antibodypedia antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Patents Similars	PubMed	n/a	n/a	>1.00E+5	n/a	n/a	n/a	n/a	n/a	n/a
COR Therapeutics, Inc Curated by ChEMBL					Assay Description Inhibition of binding of fibrinogen to purified human GPIIb-IIIa in ELISA				Bioorg Med Chem Lett 11: 1289-92 (2001) BindingDB Entry DOI: 10.7270/Q22N51KQ
					More data for this Ligand-Target Pair
Integrin alpha-IIb/beta-3 (Homo sapiens (Human))	BDBM50100354 (6-[9-(4-Carbamimidoyl-benzoyl)-3,9-diaza-spiro[5.5...) Show SMILES NC(=N)c1ccc(cc1)C(=O)N1CCC2(CCN(CC2)C(=O)CCCCC(O)=O)CC1 Show InChI InChI=1S/C23H32N4O4/c24-21(25)17-5-7-18(8-6-17)22(31)27-15-11-23(12-16-27)9-13-26(14-10-23)19(28)3-1-2-4-20(29)30/h5-8H,1-4,9-16H2,(H3,24,25)(H,29,30)	PDB KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	PubMed	n/a	n/a	>1.00E+5	n/a	n/a	n/a	n/a	n/a	n/a
COR Therapeutics, Inc Curated by ChEMBL					Assay Description Inhibitory concentration of the compound against alphaV-beta3 integrin				Bioorg Med Chem Lett 11: 1289-92 (2001) BindingDB Entry DOI: 10.7270/Q22N51KQ
					More data for this Ligand-Target Pair
Integrin alpha-V/beta-3 (Homo sapiens (Human))	BDBM50100353 (5-Oxo-5-(9-pyridin-4-yl-3,9-diaza-spiro[5.5]undec-...) Show SMILES OC(=O)CCCC(=O)N1CCC2(CC1)CCN(CC2)c1ccncc1 Show InChI InChI=1S/C19H27N3O3/c23-17(2-1-3-18(24)25)22-14-8-19(9-15-22)6-12-21(13-7-19)16-4-10-20-11-5-16/h4-5,10-11H,1-3,6-9,12-15H2,(H,24,25)	PDB UniProtKB/SwissProt antibodypedia antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Patents Similars	PubMed	n/a	n/a	>1.00E+5	n/a	n/a	n/a	n/a	n/a	n/a
COR Therapeutics, Inc Curated by ChEMBL					Assay Description Inhibition of binding of fibrinogen to purified human GPIIb-IIIa in ELISA				Bioorg Med Chem Lett 11: 1289-92 (2001) BindingDB Entry DOI: 10.7270/Q22N51KQ
					More data for this Ligand-Target Pair
Integrin alpha-V/beta-3 (Homo sapiens (Human))	BDBM50100352 (3-Oxo-3-[4-(9-pyridin-4-yl-3,9-diaza-spiro[5.5]und...) Show SMILES OC(=O)CC(=O)N1CCC(CC1)C(=O)N1CCC2(CC1)CCN(CC2)c1ccncc1 Show InChI InChI=1S/C23H32N4O4/c28-20(17-21(29)30)26-11-3-18(4-12-26)22(31)27-15-7-23(8-16-27)5-13-25(14-6-23)19-1-9-24-10-2-19/h1-2,9-10,18H,3-8,11-17H2,(H,29,30)	PDB UniProtKB/SwissProt antibodypedia antibodypedia GoogleScholar AffyNet	CHEMBL KEGG PC cid PC sid UniChem Patents Similars	PubMed	n/a	n/a	>1.00E+5	n/a	n/a	n/a	n/a	n/a	n/a
COR Therapeutics, Inc Curated by ChEMBL					Assay Description Inhibitory concentration of the compound against alphaV-beta3 integrin				Bioorg Med Chem Lett 11: 1289-92 (2001) BindingDB Entry DOI: 10.7270/Q22N51KQ
					More data for this Ligand-Target Pair
Integrin alpha-V/beta-3 (Homo sapiens (Human))	BDBM50100344 ((S)-2-Butoxycarbonylamino-5-oxo-5-(9-pyridin-4-yl-...) Show SMILES CCCCOC(=O)N[C@@H](CCC(=O)N1CCC2(CC1)CCN(CC2)c1ccncc1)C(O)=O Show InChI InChI=1S/C24H36N4O5/c1-2-3-18-33-23(32)26-20(22(30)31)4-5-21(29)28-16-10-24(11-17-28)8-14-27(15-9-24)19-6-12-25-13-7-19/h6-7,12-13,20H,2-5,8-11,14-18H2,1H3,(H,26,32)(H,30,31)/t20-/m0/s1	PDB UniProtKB/SwissProt antibodypedia antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Patents Similars	PubMed	n/a	n/a	>1.00E+5	n/a	n/a	n/a	n/a	n/a	n/a
COR Therapeutics, Inc Curated by ChEMBL					Assay Description Inhibition of binding of fibrinogen to purified human GPIIb-IIIa in ELISA				Bioorg Med Chem Lett 11: 1289-92 (2001) BindingDB Entry DOI: 10.7270/Q22N51KQ
					More data for this Ligand-Target Pair
Integrin alpha-V/beta-3 (Homo sapiens (Human))	BDBM50100345 (5-[9-(4-Carbamimidoyl-benzoyl)-3,9-diaza-spiro[5.5...) Show SMILES NC(=N)c1ccc(cc1)C(=O)N1CCC2(CCN(CC2)C(=O)CCCC(O)=O)CC1 Show InChI InChI=1S/C22H30N4O4/c23-20(24)16-4-6-17(7-5-16)21(30)26-14-10-22(11-15-26)8-12-25(13-9-22)18(27)2-1-3-19(28)29/h4-7H,1-3,8-15H2,(H3,23,24)(H,28,29)	PDB UniProtKB/SwissProt antibodypedia antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Patents Similars	PubMed	n/a	n/a	>1.00E+5	n/a	n/a	n/a	n/a	n/a	n/a
COR Therapeutics, Inc Curated by ChEMBL					Assay Description Inhibition of binding of fibrinogen to purified human GPIIb-IIIa in ELISA				Bioorg Med Chem Lett 11: 1289-92 (2001) BindingDB Entry DOI: 10.7270/Q22N51KQ
					More data for this Ligand-Target Pair
Integrin alpha-V/beta-3 (Homo sapiens (Human))	BDBM50100343 (2-{1-[9-(4-pyridyl)-3,9-diazaspiro[5.5]undec-3-ylc...) Show SMILES OC(=O)COC1CCN(CC1)C(=O)N1CCC2(CC1)CCN(CC2)c1ccncc1 Show InChI InChI=1S/C22H32N4O4/c27-20(28)17-30-19-3-11-25(12-4-19)21(29)26-15-7-22(8-16-26)5-13-24(14-6-22)18-1-9-23-10-2-18/h1-2,9-10,19H,3-8,11-17H2,(H,27,28)	PDB UniProtKB/SwissProt antibodypedia antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Patents Similars	PubMed	n/a	n/a	>1.00E+5	n/a	n/a	n/a	n/a	n/a	n/a
COR Therapeutics, Inc Curated by ChEMBL					Assay Description Inhibition of binding of fibrinogen to purified human GPIIb-IIIa in ELISA				Bioorg Med Chem Lett 11: 1289-92 (2001) BindingDB Entry DOI: 10.7270/Q22N51KQ
					More data for this Ligand-Target Pair
Integrin alpha-V/beta-3 (Homo sapiens (Human))	BDBM50100346 ((S)-2-(3,5-Dimethyl-isoxazole-4-sulfonylamino)-3-[...) Show SMILES Cc1noc(C)c1S(=O)(=O)N[C@@H](CNC(=O)N1CCC2(CC1)CCN(CC2)c1ccncc1)C(O)=O Show InChI InChI=1S/C23H32N6O6S/c1-16-20(17(2)35-26-16)36(33,34)27-19(21(30)31)15-25-22(32)29-13-7-23(8-14-29)5-11-28(12-6-23)18-3-9-24-10-4-18/h3-4,9-10,19,27H,5-8,11-15H2,1-2H3,(H,25,32)(H,30,31)/t19-/m0/s1	PDB UniProtKB/SwissProt antibodypedia antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Patents Similars	PubMed	n/a	n/a	>1.00E+5	n/a	n/a	n/a	n/a	n/a	n/a
COR Therapeutics, Inc Curated by ChEMBL					Assay Description Inhibitory concentration of the compound against alphaV-beta3 integrin				Bioorg Med Chem Lett 11: 1289-92 (2001) BindingDB Entry DOI: 10.7270/Q22N51KQ
					More data for this Ligand-Target Pair
Integrin alpha-V/beta-3 (Homo sapiens (Human))	BDBM50100342 (7-Oxo-7-(9-pyridin-4-yl-3,9-diaza-spiro[5.5]undec-...) Show SMILES OC(=O)CCCCCC(=O)N1CCC2(CC1)CCN(CC2)c1ccncc1 Show InChI InChI=1S/C21H31N3O3/c25-19(4-2-1-3-5-20(26)27)24-16-10-21(11-17-24)8-14-23(15-9-21)18-6-12-22-13-7-18/h6-7,12-13H,1-5,8-11,14-17H2,(H,26,27)	PDB UniProtKB/SwissProt antibodypedia antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Patents Similars	PubMed	n/a	n/a	>1.00E+5	n/a	n/a	n/a	n/a	n/a	n/a
COR Therapeutics, Inc Curated by ChEMBL					Assay Description Inhibitory concentration of the compound against alphaV-beta3 integrin				Bioorg Med Chem Lett 11: 1289-92 (2001) BindingDB Entry DOI: 10.7270/Q22N51KQ
					More data for this Ligand-Target Pair
Integrin alpha-V/beta-3 (Homo sapiens (Human))	BDBM50100357 (8-Oxo-8-(9-pyridin-4-yl-3,9-diaza-spiro[5.5]undec-...) Show SMILES OC(=O)CCCCCCC(=O)N1CCC2(CC1)CCN(CC2)c1ccncc1 Show InChI InChI=1S/C22H33N3O3/c26-20(5-3-1-2-4-6-21(27)28)25-17-11-22(12-18-25)9-15-24(16-10-22)19-7-13-23-14-8-19/h7-8,13-14H,1-6,9-12,15-18H2,(H,27,28)	PDB UniProtKB/SwissProt antibodypedia antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Patents Similars	PubMed	n/a	n/a	>1.00E+5	n/a	n/a	n/a	n/a	n/a	n/a
COR Therapeutics, Inc Curated by ChEMBL					Assay Description Inhibition of binding of fibrinogen to purified human GPIIb-IIIa in ELISA				Bioorg Med Chem Lett 11: 1289-92 (2001) BindingDB Entry DOI: 10.7270/Q22N51KQ
					More data for this Ligand-Target Pair
Integrin alpha-V/beta-3 (Homo sapiens (Human))	BDBM50092105 ((S)-2-(3,5-Dimethyl-isoxazole-4-sulfonylamino)-5-o...) Show SMILES Cc1noc(C)c1S(=O)(=O)N[C@@H](CCC(=O)N1CCC2(CC1)CCN(CC2)c1ccncc1)C(O)=O Show InChI InChI=1S/C24H33N5O6S/c1-17-22(18(2)35-26-17)36(33,34)27-20(23(31)32)3-4-21(30)29-15-9-24(10-16-29)7-13-28(14-8-24)19-5-11-25-12-6-19/h5-6,11-12,20,27H,3-4,7-10,13-16H2,1-2H3,(H,31,32)/t20-/m0/s1	PDB UniProtKB/SwissProt antibodypedia antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Patents Similars	PubMed	n/a	n/a	>1.00E+5	n/a	n/a	n/a	n/a	n/a	n/a
COR Therapeutics, Inc Curated by ChEMBL					Assay Description Inhibitory concentration of the compound against alphaV-beta3 integrin				Bioorg Med Chem Lett 11: 1289-92 (2001) BindingDB Entry DOI: 10.7270/Q22N51KQ
					More data for this Ligand-Target Pair